Ernst Rausch
YOU?
Author Swipe
View article: Efficacy of a new ready-to-use vaccine against PCV-2d and Mycoplasma hyopneumoniae under experimental conditions
Efficacy of a new ready-to-use vaccine against PCV-2d and Mycoplasma hyopneumoniae under experimental conditions Open
Mycoplasma hyopneumoniae (M. hyo) and porcine circovirus type 2 (PCV-2) are major and widespread swine pathogens, both implicated in the porcine respiratory disease complex, which can lead to significant economic losses for p…
View article: P-191. Outcomes of <i>Clostridioides difficile</i> Infection in Patients Treated with a Partial versus Complete Course of Fidaxomicin
P-191. Outcomes of <i>Clostridioides difficile</i> Infection in Patients Treated with a Partial versus Complete Course of Fidaxomicin Open
Background Current guidelines recommend fidaxomicin as the preferred treatment for initial and recurrent non-fulminant Clostridioides difficile infection (CDI). However, widespread use of fidaxomicin in practice is limited by high cost and…
View article: Eravacycline Associated Hypofibrinogenemia: A Case Series of Transplant Patients With Mycobacterium Abscessus Infections and Review of Literature
Eravacycline Associated Hypofibrinogenemia: A Case Series of Transplant Patients With Mycobacterium Abscessus Infections and Review of Literature Open
Eravacycline is a synthetic fluorocycline within the tetracycline class of antimicrobials. Eravacycline is active in vitro against several clinically important Gram-positive and Gram-negative bacteria. In addition, eravacycline has activit…